Active substanceDioxomethyltetrahydropyrimidineDioxomethyltetrahydropyrimidine
Similar drugsTo uncover
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    suppositories rect. 
  • Methyluracil
    pills inwards 
    UPDATE OF PFC, CJSC     Russia
  • Methyluracil
    ointment externally 
    GREEN DUBRAVA, CJSC     Russia
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    ointment locally externally 
  • Methyluracil
    suppositories rect. 
    ALTAYVITAMINS, CJSC     Russia
  • Methyluracil
    suppositories rect. 
    YUZHFARM, LLC     Russia
  • Methyluracil-ACOS
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Metouracol
    sponge externally 
  • Oxolin
    ointment externally 
  • Stisamet®
    ointment locally externally 
  • Dosage form: & nbsppills
    Composition:

    For one tablet:

    Dioxomethyltetrahydropyrimidine 500 mg

    Excipients:

    potato starch - 130 mg

    povidone-K30 - 49 mg

    talcum - 14 mg

    calcium stearate - 7 mg

    Description:

    Round, flat cylindrical tablets of white color, with a facet, with a risk on one side and engraved "R" or without it - on the other.

    Pharmacotherapeutic group:Reparation of tissue stimulant
    ATX: & nbsp

    D.11.A.X   Other preparations for the treatment of skin diseases

    L.03.A.X   Other immunostimulants

    Pharmacodynamics:

    Has anabolic activity. Has hematopoietic, leukopoetic, immunostimulating, anti-inflammatory action. Normalizing the nucleic acid metabolism, accelerates the regeneration processes in the wounds, accelerating the growth and granulation maturation of the tissue and epithelization (including in the rapidly proliferating cells of the gastrointestinal mucosa), stimulates erythro- and leukopoiesis, cellular and humoral immunity factors.

    Indications:

    Leucopenia (mild forms, including those caused by chemotherapy of malignant neoplasms, with X-ray and radiation therapy), agranulocyte angina, alimentary-toxic aleukia, anemia, thrombocytopenia, benzol intoxication, radiation sickness, convalescence (after severe infections), peptic ulcer disease stomach and duodenum (as part of combination therapy), flaccid wounds, burns, bone fractures, hepatitis, pancreatitis.

    Contraindications:Hypersensitivity, leukemia (leukemia, especially myeloid), lymphogranulomatosis, hemoblastosis, malignant neoplasms of the bone marrow, children's age - up to 3 years.
    Pregnancy and lactation:During pregnancy and lactation, the expected benefit to the mother and the potential risk to the fetus and the baby should be correlated.
    Dosing and Administration:

    Inside, during or after a meal, adults - 500 mg 4 times a day (if necessary - up to 6 times a day, the maximum daily dose - 3 g); children from 3 to 8 years - 250 mg 3 times a day (maximum daily dose - 750 mg), older than 8 years - up to 14 years, 250-500 mg 3 times a day (maximum daily dose - 1.5 g). Course in diseases of the gastrointestinal tract - 30-40 days; in other cases it may be shorter.

    Side effects:Allergic reactions, headache, dizziness, heartburn.
    Overdose:

    In the clinical application of cases of overdose before this time is not recorded.

    Interaction:Enhances the anti-radiation effect of cystamine.
    Form release / dosage:Tablets, 500 mg.
    Packaging:

    For 10 tablets in a contour mesh box made of polyvinylchloride film and aluminum foil printed lacquered.

    For 5, 10 contour squares with tablets with engraved "R" or without it, with instruction for use put in a pack of cardboard for consumer containers.20 contour cell packs with tablets without engraving "R" with instructions for use are placed in a pack of cardboard for consumer containers.

    Storage conditions:

    In the dark place at a temperaturenot more than 25 ° C.

    Keep out of the reach of children.
    Shelf life:

    5 years.

    Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LS-002574
    Date of registration:25.02.2011 / 01.11.2016
    Expiration Date:Unlimited
    The owner of the registration certificate:UPDATE OF PFC, CJSC UPDATE OF PFC, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp08.05.2018
    Illustrated instructions
      Instructions
      Up